Valentini, Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 17.059
EU - Europa 16.594
AS - Asia 5.936
AF - Africa 167
SA - Sud America 67
OC - Oceania 59
Continente sconosciuto - Info sul continente non disponibili 34
Totale 39.916
Nazione #
US - Stati Uniti d'America 16.814
DE - Germania 5.383
SE - Svezia 3.574
CN - Cina 2.375
IT - Italia 2.028
SG - Singapore 1.768
UA - Ucraina 1.333
IE - Irlanda 1.016
FR - Francia 840
ID - Indonesia 635
GB - Regno Unito 550
IN - India 484
FI - Finlandia 408
RU - Federazione Russa 397
PL - Polonia 396
TR - Turchia 252
CA - Canada 208
BE - Belgio 191
CZ - Repubblica Ceca 129
CI - Costa d'Avorio 126
JP - Giappone 89
IR - Iran 84
NL - Olanda 68
HK - Hong Kong 60
AT - Austria 56
AU - Australia 50
CH - Svizzera 47
VN - Vietnam 41
ES - Italia 38
RO - Romania 25
BR - Brasile 23
MX - Messico 23
EU - Europa 22
KR - Corea 19
PE - Perù 19
CL - Cile 18
LT - Lituania 18
IL - Israele 17
NO - Norvegia 16
PH - Filippine 15
PK - Pakistan 15
PT - Portogallo 12
GR - Grecia 11
A2 - ???statistics.table.value.countryCode.A2??? 10
RS - Serbia 10
SA - Arabia Saudita 10
MY - Malesia 9
NZ - Nuova Zelanda 9
DK - Danimarca 8
EG - Egitto 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
LK - Sri Lanka 7
PA - Panama 7
TW - Taiwan 6
IQ - Iraq 5
KZ - Kazakistan 5
MD - Moldavia 5
AM - Armenia 4
BD - Bangladesh 4
BG - Bulgaria 4
BH - Bahrain 4
HR - Croazia 4
HU - Ungheria 4
LU - Lussemburgo 4
LV - Lettonia 4
MT - Malta 4
SC - Seychelles 4
TH - Thailandia 4
AL - Albania 3
BZ - Belize 3
CY - Cipro 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
GE - Georgia 3
JO - Giordania 3
KE - Kenya 3
KW - Kuwait 3
A1 - Anonimo 2
AR - Argentina 2
MK - Macedonia 2
MU - Mauritius 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
ZA - Sudafrica 2
BY - Bielorussia 1
CM - Camerun 1
CO - Colombia 1
CU - Cuba 1
ET - Etiopia 1
IM - Isola di Man 1
KG - Kirghizistan 1
MN - Mongolia 1
MW - Malawi 1
NG - Nigeria 1
NP - Nepal 1
QA - Qatar 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 39.913
Città #
Chandler 4.030
Singapore 1.386
Ashburn 1.340
Dublin 1.011
Jacksonville 819
San Mateo 757
Ann Arbor 633
Jakarta 617
New York 527
Nanjing 515
Wilmington 514
Milan 444
Woodbridge 378
Warsaw 365
Boston 361
Dearborn 354
Beijing 294
Princeton 293
Nürnberg 289
Rome 285
Moscow 280
Fairfield 273
Houston 263
Marseille 263
Bremen 247
Lawrence 245
Cattolica 236
Izmir 218
Redwood City 203
Los Angeles 196
Brussels 188
Munich 181
Seattle 181
Nanchang 179
Zhengzhou 155
Helsinki 138
Chicago 134
Boardman 129
Abidjan 126
Leawood 91
Shenyang 91
Toronto 91
Kunming 86
Norwalk 82
Jiaxing 74
Pune 74
Hebei 73
Augusta 71
Cambridge 70
Tianjin 69
Brno 68
Mountain View 67
Changsha 66
Detroit 66
University Park 66
Washington 66
Fremont 64
Shanghai 64
Hangzhou 60
Vienna 51
London 48
Falls Church 47
Redmond 46
Phoenixville 43
North York 42
Ottawa 42
San Diego 42
Frankfurt am Main 41
Lancaster 41
Andover 40
Guangzhou 40
Hong Kong 39
Jinan 35
Leesburg 34
Hefei 31
Simi Valley 28
Hanoi 27
Kish 27
Monmouth Junction 27
Auburn Hills 23
Busto Arsizio 23
Ningbo 23
Amsterdam 22
Edinburgh 22
Paris 22
Phoenix 22
Lanzhou 21
Tokyo 21
Kraków 20
Ardabil 19
Cuauhtémoc 19
San Francisco 19
Bologna 18
Indiana 18
San Jose 18
Casalecchio di Reno 17
Dresden 17
Zurich 17
Lima 16
Chengdu 15
Totale 21.689
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 796
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 310
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 254
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 243
Neoadjuvant Concurrent Radiochemotherapy in Locally Advanced (IIIa-IIIb) Non-Small Cell Lung Cancer: long term results according to downstaging. 243
The role of radiotherapy (RT) in the treatment of Adenoid Cystic Carcinoma of the Breast: case report of RT retreatment and literature review 226
EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy 225
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 219
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study. 209
Can Elderly Patients With Newly Diagnosed Glioblastoma be Enrolled in Radiochemotherapy Trials? 200
EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series 200
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 198
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? 191
Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population 188
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 177
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 172
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 169
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 167
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 167
Medicine is a science of uncertainty and an art of probability (Sir W. Osler) 167
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 164
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 164
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 162
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 162
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 160
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 148
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 147
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 147
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 143
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 142
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 142
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. 141
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. 139
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 138
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 138
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 138
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 138
 ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose. 138
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. 137
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 137
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 137
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 136
Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study 136
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 136
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 136
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 133
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 130
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 129
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 129
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 129
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 129
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 129
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 128
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). 127
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 127
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 127
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 126
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 126
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 124
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 124
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 124
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 122
Oncological outcome of hypopharyngeal carcinoma treated with different modalities at two different university hospitals 122
Oncological outcome in advanced laryngeal cancers treated with different modalities in a single institution. A retrospective analysis on 65 cases. 121
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 121
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 120
Multiple abscesses in a patient treated with cetuximab 118
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 118
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 117
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 116
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 115
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 115
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study 115
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 112
Comparison of total laryngectomy with surgical (cricohyoidopexy) and nonsurgical organ-preservation modalities in advanced laryngeal squamous cell carcinomas: A multicenter retrospective analysis 111
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 111
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 110
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 110
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 110
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 109
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 109
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 108
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 108
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 108
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 108
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? 107
HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region 107
Lung abnormalities at multimodality imaging after radiation therapy for non-small cell lung cancer 106
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 106
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 104
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 104
Cutaneous squamous cell carcinoma. Italian guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelines 104
Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma 103
No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT) 103
Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases 102
Oncological results of the surgical salvage of recurrent laryngeal SCC in a multicentric retrospective series. The emerging role of supracricoid partial laryngectomy 102
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 102
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 102
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 102
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 102
Totale 14.658
Categoria #
all - tutte 187.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 187.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.536 0 0 0 0 430 424 538 242 574 293 673 362
2020/20213.386 204 380 108 376 504 152 341 79 370 213 546 113
2021/20225.273 515 307 103 409 253 169 80 720 234 350 1.136 997
2022/202311.269 1.575 1.543 876 1.756 672 1.318 568 877 1.256 241 414 173
2023/20245.563 230 1.524 224 369 241 861 324 300 79 191 578 642
2024/20252.944 314 360 888 432 950 0 0 0 0 0 0 0
Totale 41.093